114 related articles for article (PubMed ID: 19863486)
1. Preparation, optimisation and characterisation of lyophilised rapid disintegrating tablets based on gelatin and saccharide.
AlHusban F; Perrie Y; Mohammed AR
Curr Drug Deliv; 2010 Jan; 7(1):65-75. PubMed ID: 19863486
[TBL] [Abstract][Full Text] [Related]
2. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
3. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.
Alhusban F; Perrie Y; Mohammed AR
Eur J Pharm Biopharm; 2011 Nov; 79(3):627-34. PubMed ID: 21693189
[TBL] [Abstract][Full Text] [Related]
4. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
5. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
7. A THz spectroscopy method for quantifying the degree of crystallinity in freeze-dried gelatin/amino acid mixtures: an application for the development of rapidly disintegrating tablets.
Darkwah J; Smith G; Ermolina I; Mueller-Holtz M
Int J Pharm; 2013 Oct; 455(1-2):357-64. PubMed ID: 23850623
[TBL] [Abstract][Full Text] [Related]
8. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
9. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
Hackl E; Ermolina I
AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents.
AlHusban F; Perrie Y; Mohammed AR
Eur J Pharm Biopharm; 2010 Jun; 75(2):254-62. PubMed ID: 20332027
[TBL] [Abstract][Full Text] [Related]
11. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
12. Influence of non-water-soluble placebo pellets of different sizes on the characteristics of orally disintegrating tablets manufactured by freeze-drying.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2013 Jun; 102(6):1786-1799. PubMed ID: 23568590
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
Omar SM; AbdAlla FI; Abdelgawad NM
AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
[TBL] [Abstract][Full Text] [Related]
14. The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations.
Sznitowska M; Płaczek M; Klunder M
Acta Pol Pharm; 2005; 62(1):25-9. PubMed ID: 16022490
[TBL] [Abstract][Full Text] [Related]
15. Application of polyvinyl acetate in an innovative formulation strategy for lyophilized orally disintegrating tablets.
Vanbillemont B; De Beer T
Int J Pharm; 2020 Oct; 588():119717. PubMed ID: 32771503
[TBL] [Abstract][Full Text] [Related]
16. Freeze drying: exploring potential in development of orodispersible tablets of sumatriptan succinate.
Gugulothu D; Desai P; Pandharipande P; Patravale V
Drug Dev Ind Pharm; 2015 Mar; 41(3):398-405. PubMed ID: 24384027
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of novel fast disintegrating capsules (Fastcaps) for administration in the oral cavity.
Ciper M; Bodmeier R
Int J Pharm; 2005 Oct; 303(1-2):62-71. PubMed ID: 16111845
[TBL] [Abstract][Full Text] [Related]
18. The influence of formulation and manufacturing process parameters on the characteristics of lyophilized orally disintegrating tablets.
Jones RJ; Rajabi-Siahboomi A; Levina M; Perrie Y; Mohammed AR
Pharmaceutics; 2011 Jul; 3(3):440-57. PubMed ID: 24310589
[TBL] [Abstract][Full Text] [Related]
19. Influence of mannitol concentration on the physicochemical, mechanical and pharmaceutical properties of lyophilised mannitol.
Kaialy W; Khan U; Mawlud S
Int J Pharm; 2016 Aug; 510(1):73-85. PubMed ID: 27242312
[TBL] [Abstract][Full Text] [Related]
20. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
